Tesla (NASDAQ: TSLA) trades at roughly 330 times trailing earnings and around 180 times forward earnings, making it one of the most expensive large-cap stocks by almost any traditional measure.
The PEG ratio sits close to 6.9, a figure that would send most value-oriented investors running for the exit without a second look.
Yet the central question for current shareholders is not whether the stock looks expensive on a spreadsheet, but whether Tesla is still shaping the next decade of transportation, energy, and automation.
Second-quarter results showed revenue of around $27 billion, with automotive sales climbing approximately 23% year over year, a figure that would be the envy of most legacy automakers.
However, operating margins compressed to near 1%, and profit missed expectations following a stretch of aggressive price cuts and heavy capital spending across multiple divisions.
The near-term numbers are messy, but the investment case for holding through 2027 rests on what is being built inside the business rather than what last quarter’s income statement shows.
Tesla is pushing toward unsupervised full self-driving, robotaxi deployment, Cybercab production, and large-scale manufacturing of its Optimus humanoid robot, all simultaneously.
The company is targeting tens of thousands of humanoid robots in 2026, with ambitions to scale toward 500,000 units annually by 2027 and an eventual capacity of 1 million units per year at Fremont.
Gigafactory Texas carries even more aggressive long-term targets, with capacity projections reaching up to 10 million Optimus units per year if manufacturing and demand conditions align.
Management has discussed production costs of around $20,000 to $25,000 per robot, a price point that, if paired with viable commercial applications, could open an entirely new revenue stream independent of vehicle sales.
That kind of genuine optionality is difficult to model precisely, but it is equally difficult to dismiss when weighing whether to hold or sell a position at current prices.
Capital expenditure is guided above $25 billion for 2026, and management has itself warned about negative free cash flow while simultaneously funding Cybercab, Optimus, and proprietary chip development.
Regulatory hurdles surrounding autonomous vehicle approvals, supply chain challenges tied to robot component sourcing, and potential demand swings in the broader electric vehicle market all represent real and present risks.
The valuation today is undeniably stretched, but if full self-driving, robotaxis, and Optimus each deliver at even a fraction of their stated targets, the current share price may look far more reasonable by 2027.
